Last Updated: November 17, 2026

Details for Patent: 12,043,626

« Back to Dashboard


Which drugs does patent 12,043,626 protect, and when does it expire?

Patent 12,043,626 protects JIDEYTRO and is included in one NDA.

This patent has ten patent family members in ten countries.

Summary for Patent: 12,043,626
Title:Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
Abstract:Provided herein are solid forms comprising a compound of formula (I), or a stereoisomer, or a mixture of stereoisomers thereof, or a pharmaceutically acceptable salt thereof. Also provided herein are methods of synthesizing a compound of formula (I), pharmaceutical compositions comprising the same, and methods of treating, preventing, and managing various disorders using the compositions provided herein.
Inventor(s):Sibao Chen, Christopher G. F. COOPER, Baudouin Gerard, Joshua Courtney Horan, Jason T. KROPP, Benjamin Stephen LANE, David James Pearson
Assignee: Nuvalent Inc
Application Number:US17/957,725
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 12,043,626

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Nuvalent JIDEYTRO zidesamtinib TABLET;ORAL 220185-001 Jul 22, 2026 RX Yes No ⤷  Start Trial ⤷  Start Trial Y Y ⤷  Start Trial
Nuvalent JIDEYTRO zidesamtinib TABLET;ORAL 220185-002 Jul 22, 2026 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.